Accelerating Cell & Gene Therapy Development: From Concept to Patient

Delivering on the promise of personalized medicine is no easy feat, but the rewards to be reaped are enormous. Learn how we can now truly deliver on the promise of personalized medicine.

Discover our articles


Innovate Towards Precision Health

With the democratization of both scientific breakthroughs like omicsnanotechnology, systems biology and technological breakthroughs like 3D Printing, Internet of Things (IoT) and Artificial Intelligence (AI), Life Sciences companies now have the opportunity to leverage these advancements to deliver innovative, precision health solutions capable of adapting to the patient needs over the course of prevention, diagnosis and treatment.


Capitalizing on these accessible breakthroughs ensures:

The New Era of Extreme Bionics - Science in the Age of Experience

Society is at the threshold of a new age when machines will no longer be separate, lifeless mechanisms, but will instead be intimate extensions of the human body. Such a merging of body and machine will not only improve the quality of life for disabled people, but will allow persons with normal physiologies to experience augmented capabilities – cognitively, emotionally and physically.


Accelerated Collaborative & Scientific Innovation

Collaborative Scientific Innovation enhances the virtual workspace with new mobile applications and tools, allowing project teams to leverage social communication for building and sharing project information. The result is a more holistic collaboration strategy for partnering pharmaceutical and biotechnology companies, contract research organizations (CROs) and academic research teams. 


The 3DEXPERIENCE® platform accelerates collaboration and scientific innovation enabling Life Sciences companies to create superior therapeutic experiences in one virtual environment with transformed collaboration, unparalleled access to knowledge and know-how, data and data analytics and modeling & simulation to drive sustainable innovations with full visibility across their internal and external ecosystems.

The transformative power of data in the patient equation

“As a result of breakthroughs in data analysis, we stand on the verge of a life sciences industry powered not by trial and error, but by a virtuous cycle of experimental evidence that brings new insights, new applications, new refinements and new successes.” Glen de Vries: Co-Founder and Co-CEO, Medidata, a Dassault Systèmes company

Explore our Industry Solution Experiences

Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.

More Life Sciences & Healthcare Challenges